• Pharma
  • June 5, 2025
  • 500 views
NPPA fixes retail prices for 41 drug combinations, including empagliflozin

The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 41 drug combinations, including 18 variants of the off-patent diabetes drug empagliflozin, originally developed by German pharmaceutical company…

  • Pharma
  • December 3, 2019
  • 298 views
Atorvastatin banned by the UP State Medical Supplies Corporation

The UP state government banned to use substandard cardiac medicine “Atorvastatin” and recalls from govt hospitals. Medicine was supplied to over 160 government hospitals in Uttar Pradesh, failed on quality…